Evidence map›Paper›PMID 36432019›Full record

ArticleMolecules (Basel, Switzerland)2022

Standardized Pomegranate (Pomella

Huifang Li, Tithi Roy, Samuel T Boateng, Hao He, Chang Liu, Weixi Liu, Dongli Li, Panpan Wu, Navindra P Seeram, Jean Christopher Chamcheu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Efficacy and safety of a proprietaryAmerican journal of translational research · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Huifang LiSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.
Tithi RoySchool of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA 71209, USA.
Samuel T BoatengSchool of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA 71209, USA.
Hao HeSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.
Chang LiuBioactive Botanical Research Laboratory, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.
Weixi LiuBioactive Botanical Research Laboratory, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.
Dongli LiSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.ORCID 0000-0001-9955-2304
Panpan WuSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.ORCID 0000-0002-6515-0726
Navindra P SeeramBioactive Botanical Research Laboratory, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.ORCID 0000-0001-7064-2904
Jean Christopher ChamcheuSchool of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA 71209, USA.ORCID 0000-0002-3927-5664
Hang MaSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.ORCID 0000-0001-7565-6889
University of Rhode Island · USUniversity of Louisiana at Monroe · USWuyi University · CN

Funding

Training CoreP20GM103430 · NIGMS · UNIVERSITY OF RHODE ISLAND · PI Christopher Lee Hemme · 2012 to 2026
$63.6M
STABILITY' (symptomatic review during biologic therapy) Review in Inflammatory Bowel DiseaseP20GM103424 · NIGMS · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI VLADIMIR N CHOULJENKO · 2012 to 2026
$57.4M
Department of Education of Guangdong Province No: 2017KSYS010, 2019KZDZX2003Jiangmen Program for Innovative Research Team No: 2018630100180019806LBRN-INBRE-COBRE Administrative Supplement Award from an IDeA NIH/NIGMS 3P20GM103424-18S1LBRN Pilot and full project Awards from an IDeA NIH/NIGMS grant P20GM12345Louisiana Board of Regents Support Fund LEQSF (2021-24)-RD-A-22National Natural Science Foundation of China No. 81803390NIGMS NIH HHS P20 GM103424NIGMS NIH HHS P20 GM103430
6 · The paper itself

Abstract

Phenolics enriched pomegranate fruit (Pomella

Indexed as

AcerPomegranateCollagenCollagenasesCollagen Type IFruitHumansHydrolyzable TanninsMatrix MetalloproteinasesPhenolsCollagenCollagenasesCollagen Type IHydrolyzable TanninsMatrix MetalloproteinasesPhenolspunicalaginanti-skin-agingcollagenasecross-linkingginnalin Apomegranate (Punica granatum)punicalaginred maple (Acer rubrum)

Identifiers

PMID36432019
PMCPMC9696304
OpenAlexW4309606528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.